Search by Drug Name or NDC

    NDC 00469-0687-11 ASTAGRAF XL 5 mg/1 Details

    ASTAGRAF XL 5 mg/1

    ASTAGRAF XL is a ORAL CAPSULE, COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Astellas Pharma US, Inc.. The primary component is TACROLIMUS.

    Product Information

    NDC 00469-0687
    Product ID 0469-0687_15be9383-263f-4080-bda4-2ab0bdfbf239
    Associated GPIs 99404080007020
    GCN Sequence Number 062898
    GCN Sequence Number Description tacrolimus CAP ER 24H 5 MG ORAL
    HIC3 Z2E
    HIC3 Description IMMUNOSUPPRESSIVES
    GCN 98664
    HICL Sequence Number 020974
    HICL Sequence Number Description TACROLIMUS
    Brand/Generic Brand
    Proprietary Name ASTAGRAF XL
    Proprietary Name Suffix n/a
    Non-Proprietary Name tacrolimus extended-release capsules
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name TACROLIMUS
    Labeler Name Astellas Pharma US, Inc.
    Pharmaceutical Class Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA204096
    Listing Certified Through 2024-12-31

    Package

    NDC 00469-0687-11 (00469068711)

    NDC Package Code 0469-0687-11
    Billing NDC 00469068711
    Package 5 BLISTER PACK in 1 CARTON (0469-0687-11) / 10 CAPSULE, COATED, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2013-07-19
    NDC Exclude Flag N
    Pricing Information N/A